This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Garancini M, Goffredo P, Pagni F, Romano F, Roman S, Sosa JA, et al. Combined hepatocellular-cholangiocarcinoma: a population-level analysis of an uncommon primary liver tumor. Liver Transpl 2014; 20: 952-9. doi: 10.1002/lt.23897GaranciniMGoffredoPPagniFRomanoFRomanSSosaJAet alCombined hepatocellular-cholangiocarcinoma: a population-level analysis of an uncommon primary liver tumorLiver Transpl201420952910.1002/lt.2389724777610Open DOISearch in Google Scholar
Joo I, Kim H, Lee JM. Cancer stem cells in primary liver cancers: pathological concepts and imaging findings. Korean J Radiol 2015; 16: 50-68. doi: 10.3348/kjr.2015.16.1.50JooIKimHLeeJMCancer stem cells in primary liver cancers: pathological concepts and imaging findingsKorean J Radiol201516506810.3348/kjr.2015.16.1.50429627825598674Open DOISearch in Google Scholar
Gera S, Ettel M, Acosta-Gonzalez G, Xu R. Clinical features, histology, and histogenesis of combined hepatocellular-cholangiocarcinoma. World J Hepatol 2017; 9: 300-9. doi: 10.4254/ wjh. v9. i6.300GeraSEttelMAcosta-GonzalezGXuRClinical features, histology, and histogenesis of combined hepatocellular-cholangiocarcinomaWorld J Hepatol20179300910.4254/wjh.v9.i6.300533241928293379Open DOISearch in Google Scholar
Akiba J, Nakashima O, Hattori S, Tanikawa K, Takenaka M, Nakayama M, et al. Clinicopathologic analysis of combined hepatocellular-cholangiocarcinoma according to the latest WHO classification. Am J Surg Pathol 2013; 37: 496-505. doi: 10.1097/PAS.0b013e31827332b0AkibaJNakashimaOHattoriSTanikawaKTakenakaMNakayamaMet alClinicopathologic analysis of combined hepatocellular-cholangiocarcinoma according to the latest WHO classificationAm J Surg Pathol20133749650510.1097/PAS.0b013e31827332b023388123Open DOISearch in Google Scholar
Portolani N, Baiocchi GL, Coniglio A, Piardi T, Grazioli L, Benetti A, et al. Intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma: a Western experience. Ann Surg Oncol 2008; 15: 1880-90. doi: 10.1245/s10434-008-9933-yPortolaniNBaiocchiGLConiglioAPiardiTGrazioliLBenettiAet alIntrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma: a Western experienceAnn Surg Oncol20081518809010.1245/s10434-008-9933-y18443881Open DOISearch in Google Scholar
Yeh MM. Pathology of combined hepatocellular-cholangiocarcinoma. J Gastroenterol Hepatol 2010; 25: 1485-92. doi: 10.1111/j.1440-1746. 2010.06430.xYehMMPathology of combined hepatocellular-cholangiocarcinomaJ Gastroenterol Hepatol20102514859210.1111/j.1440-1746.2010.06430.x20796144Open DOISearch in Google Scholar
Yoon YI, Hwang S, Lee YJ, Kim KH, Ahn CS, Moon DB, et al. Postresection outcomes of combined hepatocellular carcinoma-cholangiocarcinoma, hepato-cellular carcinoma and intrahepatic cholangiocarcinoma. J Gastrointest Surg 2016; 20: 411-20. doi: 10.1007/s11605-015-3045-3YoonYIHwangSLeeYJKimKHAhnCSMoonDBet alPostresection outcomes of combined hepatocellular carcinoma-cholangiocarcinoma, hepato-cellular carcinoma and intrahepatic cholangiocarcinomaJ Gastrointest Surg2016204112010.1007/s11605-015-3045-326628072Open DOISearch in Google Scholar
Allen RA, Lisa JR. Combined liver cell and bile duct carcinoma. Am J Pathol 1949; 25: 647-55. PMID: 18152860AllenRALisaJRCombined liver cell and bile duct carcinomaAm J Pathol19492564755PMID: 18152860Search in Google Scholar
Okuda K. Natural history of hepatocellular carcinoma including fibrolamellar and hepato-cholangiocarcinoma variants. J Gastroenterol Hepatol 2002; 17: 401-5. doi: 10.1046/j.1440-1746.2002.02734.xOkudaKNatural history of hepatocellular carcinoma including fibrolamellar and hepato-cholangiocarcinoma variantsJ Gastroenterol Hepatol200217401510.1046/j.1440-1746.2002.02734.x11982719Open DOISearch in Google Scholar
Zhou YM, Zhang XF, Wu LP, Sui CJ, Yang JM. Risk factors for combined hepatocellular-cholangiocarcinoma: a hospital-based case-control study. World J Gastroenterol 2014; 20: 12615-20. doi: 10.3748/wjg.v20.i35.12615ZhouYMZhangXFWuLPSuiCJYangJMRisk factors for combined hepatocellular-cholangiocarcinoma: a hospital-based case-control studyWorld J Gastroenterol201420126152010.3748/wjg.v20.i35.12615416809925253966Open DOISearch in Google Scholar
Granata V, Fusco R, Filice S, Catalano O, Piccirillo M, Palaia R, et al. The current role and future prospectives of functional parameters by diffusion weighted imaging in the assessment of histologic grade of HCC. Infect Agent Cancer 2018; 13: 23. doi: 10.1186/s13027-018-0194-5GranataVFuscoRFiliceSCatalanoOPiccirilloMPalaiaRet alThe current role and future prospectives of functional parameters by diffusion weighted imaging in the assessment of histologic grade of HCCInfect Agent Cancer2018132310.1186/s13027-018-0194-5602934829988667Open DOISearch in Google Scholar
Granata V, Fusco R, Avallone A, Filice F, Tatangelo F, Piccirillo M, et al. Critical analysis of the major and ancillary imaging features of LI-RADS on 127 proven HCCs evaluated with functional and morphological MRI: lights and shadows. Oncotarget 2017; 8: 51224-37. doi: 10.18632/oncotarget.17227GranataVFuscoRAvalloneAFiliceFTatangeloFPiccirilloMet alCritical analysis of the major and ancillary imaging features of LI-RADS on 127 proven HCCs evaluated with functional and morphological MRI: lights and shadowsOncotarget20178512243710.18632/oncotarget.17227Open DOISearch in Google Scholar
Granata V, Fusco R, Avallone A, Catalano O, Filice F, Leongito M, et al. Major and ancillary magnetic resonance features of LI-RADS to assess HCC: an overview and update. Infect Agent Cancer 2017; 12: 23. doi: 10.1186/ s13027-017-0132-yGranataVFuscoRAvalloneACatalanoOFiliceFLeongitoMet alMajor and ancillary magnetic resonance features of LI-RADS to assess HCC: an overview and updateInfect Agent Cancer2017122310.1186/s13027-017-0132-yOpen DOISearch in Google Scholar
Granata V, Fusco R, Catalano O, Guarino B, Granata F, Tatangelo F, et al. Intravoxel incoherent motion (IVIM) in diffusion-weighted imaging (DWI) for hepatocellular carcinoma: correlation with histologic grade. Oncotarget 2016; 7: 79357-64. doi: 10.18632/oncotarget.12689GranataVFuscoRCatalanoOGuarinoBGranataFTatangeloFet alIntravoxel incoherent motion (IVIM) in diffusion-weighted imaging (DWI) for hepatocellular carcinoma: correlation with histologic gradeOncotarget20167793576410.18632/oncotarget.12689Open DOISearch in Google Scholar
Granata V, de Lutio di Castelguidone E, Fusco R, Catalano O, Piccirillo M, Palaia R, et al. Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area. Radiol Med 2016; 121: 122-31. doi: 10.1007/s11547-015-0582-5.GranataVde Lutiodi Castelguidone EFuscoRCatalanoOPiccirilloMPalaiaRet alIrreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated areaRadiol Med20161211223110.1007/s11547-015-0582-5Open DOISearch in Google Scholar
Zhang XY, Luo Y, Wen TF, Jiang L, Li C, Zhong XF, et al. Contrast-enhanced ultrasound: improving the preoperative staging of hepatocellular carcinoma and guiding individual treatment. World J Gastroenterol 2014; 20: 1262836. doi: 10.3748/wjg.v20.i35.12628ZhangXYLuoYWenTFJiangLLiCZhongXFet alContrast-enhanced ultrasound: improving the preoperative staging of hepatocellular carcinoma and guiding individual treatmentWorld J Gastroenterol201420126283610.3748/wjg.v20.i35.12628Open DOISearch in Google Scholar
Ayuso C, Rimola J, García-Criado A. Imaging of HCC. Abdom Imaging 2012; 37: 215-30. doi: 10.1007/s00261-011-9794-xAyusoCRimolaJGarcía-CriadoAImaging of HCCAbdom Imaging2012372153010.1007/s00261-011-9794-xOpen DOISearch in Google Scholar
Jeon SK, Joo I, Lee DH, Lee SM, Kang HJ, Lee KB, et al. Combined hepato-cellular cholangiocarcinoma: LI-RADS v2017 categorisation for differential diagnosis and prognostication on gadoxetic acid-enhanced MR imaging. Eur Radiol 2019; 29: 373-82. doi: 10.1007/s00330-018-5605-xJeonSKJooILeeDHLeeSMKangHJLeeKBet alCombined hepato-cellular cholangiocarcinoma: LI-RADS v2017 categorisation for differential diagnosis and prognostication on gadoxetic acid-enhanced MR imagingEur Radiol2019293738210.1007/s00330-018-5605-xOpen DOISearch in Google Scholar
The American College of Radiology. Liver Reporting & Data System (LI-RADS). [cited 2020 Jan 15]. Available at: https://www.acr.org/Clinical-Resources/Reporting-and-Data-Systems/LI-RADSThe American College of Radiology. Liver Reporting & Data System (LI-RADS)[cited 2020 Jan 15]. Available athttps://www.acr.org/Clinical-Resources/Reporting-and-Data-Systems/LI-RADSSearch in Google Scholar
Edmondson HA, Steiner PE. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 1954; 7: 462-503. doi: 10.1002/1097-0142(195405)7:3<462::aid-cncr2820070308>3.0.co;2-eEdmondsonHASteinerPEPrimary carcinoma of the liver: a study of 100 cases among 48,900 necropsiesCancer1954746250310.1002/1097-0142(195405)7:3<462::aid-cncr2820070308>3.0.co;2-eOpen DOISearch in Google Scholar
Lee HS, Kim MJ, An C. How to utilize LR-M features of the LI-RADS to improve the diagnosis of combined hepatocellular-cholangiocarcinoma on gadoxetate-enhanced MRI? Eur Radiol 2019; 29: 2408-16. doi: 10.1007/ s00330-018-5893-1LeeHSKimMJAnCHow to utilize LR-M features of the LI-RADS to improve the diagnosis of combined hepatocellular-cholangiocarcinoma on gadoxetate-enhanced MRI?Eur Radiol20192924081610.1007/s00330-018-5893-1Open DOISearch in Google Scholar
Potretzke TA, Tan BR, Doyle MB, Brunt EM, Heiken JP, Fowler KJ. Imaging features of biphenotypic primary liver carcinoma (hepatocholangiocarcinoma) and the potential to mimic hepato- cellular carcinoma: LI-RADS analysis of CT and MRI features in 61 cases. AJR Am J Roentgenol 2016; 207: 25-31. doi: 10.2214/AJR.15.14997PotretzkeTATanBRDoyleMBBruntEMHeikenJPFowlerKJImaging features of biphenotypic primary liver carcinoma (hepatocholangiocarcinoma) and the potential to mimic hepato- cellular carcinoma: LI-RADS analysis of CT and MRI features in 61 casesAJR Am J Roentgenol2016207253110.2214/AJR.15.14997Open DOISearch in Google Scholar
Sammon J, Fischer S, Menezes R, Hosseini-Nik H, Lewis S, Taouli B, et al. MRI features of combined hepatocellular-cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma. Cancer Imaging 2018; 18: 8. doi: 10.1186/s40644-018-0142-zSammonJFischerSMenezesRHosseini-NikHLewisSTaouliBet alMRI features of combined hepatocellular-cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinomaCancer Imaging201818810.1186/s40644-018-0142-z583005329486800Open DOISearch in Google Scholar
Fowler KJ, Sheybani A, Parker RA 3rd, Doherty S, M Brunt E, Chapman WC, et al. Combined hepatocellular and cholangiocarcinoma (biphenotypic) tumors: imaging features and diagnostic accuracy of contrast-enhanced CT and MRI. AJR Am J Roentgenol 2013; 201: 332-9. doi: 10.2214/AJR.12.9488FowlerKJSheybaniAParkerRA3rdDohertySMBrunt EChapmanWCet alCombined hepatocellular and cholangiocarcinoma (biphenotypic) tumors: imaging features and diagnostic accuracy of contrast-enhanced CT and MRIAJR Am J Roentgenol2013201332910.2214/AJR.12.948823883213Open DOISearch in Google Scholar
Kim JE, Kim SH, Lee SJ, Rhim H. Hypervascular hepatocellular carcinoma 1 cm or smaller in patients with chronic liver disease: characterization with gadoxetic acid-enhanced MRI that includes diffusion-weighted imaging. AJR Am J Roentgenol 2011; 196: W758-65. doi: 10.2214/AJR.10.4394KimJEKimSHLeeSJRhimHHypervascular hepatocellular carcinoma 1 cm or smaller in patients with chronic liver disease: characterization with gadoxetic acid-enhanced MRI that includes diffusion-weighted imagingAJR Am J Roentgenol2011196W7586510.2214/AJR.10.439421606265Open DOISearch in Google Scholar
